{"count": 4, "results": [{"_id": "31072935", "pmid": 31072935, "pmcid": "PMC6561162", "title": "Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis", "journal": "Proc Natl Acad Sci U S A", "authors": ["Eshaghi A", "Kievit RA", "Prados F", "Sudre CH", "Nicholas J", "Cardoso MJ", "Chan D", "Nicholas R", "Ourselin S", "Greenwood J", "Thompson AJ", "Alexander DC", "Barkhof F", "Chataway J", "Ciccarelli O"], "date": "2019-05-28T00:00:00Z", "doi": "10.1073/pnas.1818978116", "meta_date_publication": "2019 May 28", "meta_volume": "116", "meta_issue": "22", "meta_pages": "11020-11027", "score": 50069.11, "text_hl": "A subsidiary aim was to investigate whether the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Microphthalmia_Syndromic_10</m> @DISEASE_MESH:C566985 @@@brain atrophy@@@ was targeting specific regions.", "citations": {"NLM": "Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O. Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. PMID: 31072935", "BibTeX": "@article{31072935, title={Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis}, author={Eshaghi A and Kievit RA and Prados F and Sudre CH and Nicholas J and Cardoso MJ and Chan D and Nicholas R and Ourselin S and Greenwood J and Thompson AJ and Alexander DC and Barkhof F and Chataway J and Ciccarelli O}, journal={Proc Natl Acad Sci U S A}, volume={116}, number={22}, pages={11020-11027}}"}}, {"_id": "24655729", "pmid": 24655729, "title": "Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.", "journal": "Lancet", "authors": ["Chataway J", "Schuerer N", "Alsanousi A", "Chan D", "MacManus D", "Hunter K", "Anderson V", "Bangham CR", "Clegg S", "Nielsen C", "Fox NC", "Wilkie D", "Nicholas JM", "Calder VL", "Greenwood J", "Frost C", "Nicholas R"], "date": "2014-06-28T00:00:00Z", "doi": "10.1016/S0140-6736(13)62242-4", "meta_date_publication": "2014 Jun 28", "meta_volume": "383", "meta_issue": "9936", "meta_pages": "2213-21", "score": 50062.23, "text_hl": "INTERPRETATION: High-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced the annualised rate of whole-@<m>DISEASE_Microphthalmia_Syndromic_10</m> @DISEASE_MESH:C566985 @@@brain atrophy@@@ compared with placebo, and was well tolerated and safe. ", "citations": {"NLM": "Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR, Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas R. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet. 2014 Jun 28;383(9936):2213-21. PMID: 24655729", "BibTeX": "@article{24655729, title={Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.}, author={Chataway J and Schuerer N and Alsanousi A and Chan D and MacManus D and Hunter K and Anderson V and Bangham CR and Clegg S and Nielsen C and Fox NC and Wilkie D and Nicholas JM and Calder VL and Greenwood J and Frost C and Nicholas R}, journal={Lancet}, volume={383}, number={9936}, pages={2213-21}}"}}, {"_id": "28600189", "pmid": 28600189, "pmcid": "PMC5507768", "title": "Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial", "journal": "Lancet Neurol", "authors": ["Chan D", "Binks S", "Nicholas JM", "Frost C", "Cardoso MJ", "Ourselin S", "Wilkie D", "Nicholas R", "Chataway J"], "date": "2017-08-01T00:00:00Z", "doi": "10.1016/S1474-4422(17)30113-8", "meta_date_publication": "2017 Aug", "meta_volume": "16", "meta_issue": "8", "meta_pages": "591-600", "score": 50042.457, "text_hl": "In the 24-month MS-STAT phase 2 trial, we showed that high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ significantly reduced the annualised rate of whole @<m>DISEASE_Microphthalmia_Syndromic_10</m> @DISEASE_MESH:C566985 @@@brain atrophy@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Multiple_Sclerosis_Chronic_Progressive @DISEASE_MESH:D020528 @@@secondary progressive multiple sclerosis@@@ (@DISEASE_Multiple_Sclerosis_Chronic_Progressive @DISEASE_MESH:D020528 @@@SPMS@@@). ", "citations": {"NLM": "Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R, Chataway J. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial Lancet Neurol. 2017 Aug;16(8):591-600. PMID: 28600189", "BibTeX": "@article{28600189, title={Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial}, author={Chan D and Binks S and Nicholas JM and Frost C and Cardoso MJ and Ourselin S and Wilkie D and Nicholas R and Chataway J}, journal={Lancet Neurol}, volume={16}, number={8}, pages={591-600}}"}}, {"_id": "29627873", "pmid": 29627873, "title": "Disease-Modifying Treatment in Progressive Multiple Sclerosis.", "journal": "Curr Treat Options Neurol", "authors": ["Ciotti JR", "Cross AH"], "date": "2018-04-07T00:00:00Z", "doi": "10.1007/s11940-018-0496-3", "meta_date_publication": "2018 Apr 7", "meta_volume": "20", "meta_issue": "5", "meta_pages": "12", "score": 50040.535, "text_hl": "Smaller early phase studies of @CHEMICAL_Thioctic_Acid @CHEMICAL_MESH:D008063 @@@alpha-lipoic acid@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ each found slowing of rate of whole @<m>DISEASE_Microphthalmia_Syndromic_10</m> @DISEASE_MESH:C566985 @@@brain atrophy@@@ in @DISEASE_Multiple_Sclerosis_Chronic_Progressive @DISEASE_MESH:D020528 @@@SPMS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Ciotti JR, Cross AH. Disease-Modifying Treatment in Progressive Multiple Sclerosis. Curr Treat Options Neurol. 2018 Apr 7;20(5):12. PMID: 29627873", "BibTeX": "@article{29627873, title={Disease-Modifying Treatment in Progressive Multiple Sclerosis.}, author={Ciotti JR and Cross AH}, journal={Curr Treat Options Neurol}, volume={20}, number={5}, pages={12}}"}}]}